Michael J. O’Connell

27.4k total citations · 8 hit papers
230 papers, 18.4k citations indexed

About

Michael J. O’Connell is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Michael J. O’Connell has authored 230 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Oncology, 65 papers in Pathology and Forensic Medicine and 53 papers in Surgery. Recurrent topics in Michael J. O’Connell's work include Colorectal Cancer Treatments and Studies (77 papers), Colorectal Cancer Surgical Treatments (65 papers) and Colorectal and Anal Carcinomas (42 papers). Michael J. O’Connell is often cited by papers focused on Colorectal Cancer Treatments and Studies (77 papers), Colorectal Cancer Surgical Treatments (65 papers) and Colorectal and Anal Carcinomas (42 papers). Michael J. O’Connell collaborates with scholars based in United States, United Kingdom and Canada. Michael J. O’Connell's co-authors include Charles G. Moertel, Greg Yothers, Norman Wolmark, Daniel J. Sargent, Leonard L. Gunderson, Larry K. Kvols, Joseph Rubin, Linda H. Colangelo, Nicholas J. Petrelli and Daniel G. Haller and has published in prestigious journals such as New England Journal of Medicine, JAMA and Angewandte Chemie International Edition.

In The Last Decade

Michael J. O’Connell

225 papers receiving 17.8k citations

Hit Papers

Improving Adjuvant Therapy for Rectal Cancer by Combining... 1979 2026 1994 2010 1994 2009 1986 1991 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery
    1994 820 citations Michael J. O’Connell, James A. Martenson et al. profile →
  2. Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
    2009 690 citations Linda H. Colangelo, Michael J. O’Connell et al. Journal of Clinical Oncology profile →
  3. Treatment of the Malignant Carcinoid Syndrome
    1986 656 citations Michael J. O’Connell et al. profile →
  4. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
    1991 610 citations Michael J. O’Connell et al. Cancer profile →
  5. Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials
    2005 520 citations Daniel J. Sargent, Daniel G. Haller et al. Journal of Clinical Oncology profile →
  6. High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy
    1985 449 citations Michael J. O’Connell et al. profile →
  7. Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
    2011 435 citations Greg Yothers, Michael J. O’Connell et al. Journal of Clinical Oncology profile →
  8. Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer
    1979 416 citations Michael J. O’Connell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. O’Connell United States 68 11.9k 5.0k 4.6k 3.7k 2.2k 230 18.4k
Susan S. Devesa United States 90 11.5k 1.0× 7.8k 1.6× 4.8k 1.0× 8.0k 2.2× 5.4k 2.5× 205 30.5k
Lynn A. G. Ries United States 56 13.0k 1.1× 3.7k 0.7× 3.2k 0.7× 6.6k 1.8× 4.1k 1.9× 81 26.7k
J.W.W. Coebergh Netherlands 87 16.3k 1.4× 5.3k 1.1× 4.2k 0.9× 6.4k 1.7× 3.9k 1.8× 520 30.6k
Richard L. Schilsky United States 75 13.8k 1.2× 2.3k 0.5× 3.2k 0.7× 6.0k 1.6× 4.8k 2.2× 382 23.2k
Patrick J. Loehrer United States 70 6.9k 0.6× 7.8k 1.6× 1.8k 0.4× 4.8k 1.3× 3.3k 1.5× 362 18.6k
David P. Ryan United States 62 9.9k 0.8× 3.6k 0.7× 1.4k 0.3× 3.9k 1.1× 3.8k 1.7× 423 17.1k
Phyllis A. Wingo United States 52 9.4k 0.8× 3.0k 0.6× 2.3k 0.5× 4.9k 1.3× 4.2k 1.9× 105 20.8k
Alan Cantor United States 69 4.6k 0.4× 1.9k 0.4× 2.1k 0.4× 2.6k 0.7× 6.9k 3.1× 286 17.8k
Kari Hemminki Sweden 86 10.1k 0.8× 3.8k 0.8× 4.9k 1.1× 4.3k 1.2× 12.3k 5.6× 1.0k 35.2k
Charles D. Blanke United States 57 8.5k 0.7× 5.8k 1.2× 2.1k 0.5× 9.6k 2.6× 2.2k 1.0× 292 18.5k

Countries citing papers authored by Michael J. O’Connell

Since Specialization
Citations

This map shows the geographic impact of Michael J. O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. O’Connell more than expected).

Fields of papers citing papers by Michael J. O’Connell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. O’Connell. The network helps show where Michael J. O’Connell may publish in the future.

Co-authorship network of co-authors of Michael J. O’Connell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. O’Connell. A scholar is included among the top collaborators of Michael J. O’Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. O’Connell. Michael J. O’Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connell, Michael J., et al.. (2025). Enhancing photosynthesis under salt stress via directed evolution in cyanobacteria. PLANT PHYSIOLOGY. 198(2). 1 indexed citations
2.
3.
Niner, Sara, et al.. (2018). How development happens: Safe and sustainable energy, community development projects, and implementation challenges in Timor‐Leste. Annals of Anthropological Practice. 42(2). 68–80. 1 indexed citations
4.
Ganzel, Chezi, Zhuoxin Sun, Larry D. Cripe, et al.. (2018). Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience. American Journal of Hematology. 93(8). 1074–1081. 100 indexed citations
5.
Wang, Chengwei, Michael J. O’Connell, & Candace K. Chan. (2015). Facile One-Pot Synthesis of Highly Porous Carbon Foams for High-Performance Supercapacitors Using Template-Free Direct Pyrolysis. ACS Applied Materials & Interfaces. 7(16). 8952–8960. 95 indexed citations
6.
McCleary, Nadine J., Jeffrey A. Meyerhardt, Erin Green, et al.. (2013). Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database. Journal of Clinical Oncology. 31(20). 2600–2606. 157 indexed citations
7.
8.
Hubbard, Joleen M., David M. Thomas, Greg Yothers, et al.. (2012). Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set. Journal of Clinical Oncology. 30(19). 2334–2339. 32 indexed citations
9.
Gavin, Patrick G., Linda H. Colangelo, Debora Fumagalli, et al.. (2012). Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value. Clinical Cancer Research. 18(23). 6531–6541. 240 indexed citations
10.
Yothers, Greg, Michael J. O’Connell, Carmen J. Allegra, et al.. (2011). Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses. Journal of Clinical Oncology. 29(28). 3768–3774. 435 indexed citations breakdown →
11.
Allegra, Carmen J., Greg Yothers, Michael J. O’Connell, et al.. (2010). Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08. Journal of Clinical Oncology. 29(1). 11–16. 410 indexed citations
12.
O’Connell, Michael J., Ian C. Lavery, Greg Yothers, et al.. (2010). Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin. Journal of Clinical Oncology. 28(25). 3937–3944. 220 indexed citations
13.
Monga, Dulabh & Michael J. O’Connell. (2006). Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions. Annals of Surgical Oncology. 13(8). 1021–1034. 46 indexed citations
14.
D’Andre, Stacy D., Daniel J. Sargent, S. Stephen, et al.. (2005). 5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study. Clinical Colorectal Cancer. 4(5). 325–331. 36 indexed citations
15.
Sloan, Jeff A., Richard M. Goldberg, Daniel J. Sargent, et al.. (2002). Women Experience Greater Toxicity With Fluorouracil-Based Chemotherapy for Colorectal Cancer. Journal of Clinical Oncology. 20(6). 1491–1498. 127 indexed citations
16.
Oken, Martin M., Robert A. Kyle, Philip R. Greipp, et al.. (1996). Complete remission induction with combined VBMCP chemotherapy and interferon (rIFNα2b) in patients with multiple myeloma. Leukemia & lymphoma. 20(5-6). 447–452. 17 indexed citations
17.
Martenson, James A., Rodolfo E. Urias, Stephen R. Smalley, et al.. (1995). Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 32(1). 51–55. 14 indexed citations
18.
Suzuki, Kimitaka, Richard M. Devine, Roger R. Dozois, et al.. (1995). Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer. 75(4). 939–952. 165 indexed citations
19.
Oken, Martin M., et al.. (1990). Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study. Leukemia & lymphoma. 1(2). 95–100. 11 indexed citations
20.
O’Connell, Michael J., David P. Harrington, John D. Earle, et al.. (1988). Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage ii aggressive histologic type non-hodgkin's lymphoma. Cancer. 61(9). 1754–1758. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan S. Devesa Breakdown of academic impact, for papers by Lynn A. G. Ries Breakdown of academic impact, for papers by J.W.W. Coebergh Breakdown of academic impact, for papers by Richard L. Schilsky Breakdown of academic impact, for papers by Patrick J. Loehrer Breakdown of academic impact, for papers by David P. Ryan Breakdown of academic impact, for papers by Phyllis A. Wingo Breakdown of academic impact, for papers by Alan Cantor Breakdown of academic impact, for papers by Kari Hemminki Breakdown of academic impact, for papers by Charles D. Blanke
Rankless by CCL
2026